Join
Live feed
·
NEWSReleasevia Quantisnow
NeuBase Therapeutics Inc. logo

On May 2, Nasdaq Notified NeuBase Therapeutics Inc That It Has Not Regained Compliance With Minimum Bid Price Requirement

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NBSE (NeuBase Therapeutics Inc.) and more on Quantisnow.